Stock Ratios
Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.
profit margin TTM
-3.12%
operating margin TTM
1.01%
revenue TTM
554.65 Million
revenue per share TTM
25.62$
valuation ratios | |
|---|---|
| pe ratio | -58.28 |
| peg ratio | 4.58 |
| price to book ratio | 2.93 |
| price to sales ratio | 2.01 |
| enterprise value multiple | 15.59 |
| price fair value | 2.93 |
profitability ratios | |
|---|---|
| gross profit margin | 57.16% |
| operating profit margin | 1.01% |
| pretax profit margin | -4.09% |
| net profit margin | -3.12% |
| return on assets | -1.63% |
| return on equity | -4.86% |
| return on capital employed | 0.63% |
liquidity ratio | |
|---|---|
| current ratio | 2.66 |
| quick ratio | 1.98 |
| cash ratio | 0.74 |
efficiency ratio | |
|---|---|
| days of inventory outstanding | 173.67 |
| operating cycle | 292.98 |
| days of payables outstanding | 67.06 |
| cash conversion cycle | 225.92 |
| receivables turnover | 3.06 |
| payables turnover | 5.44 |
| inventory turnover | 2.10 |
debt and solvency ratios | |
|---|---|
| debt ratio | 0.25 |
| debt equity ratio | 0.76 |
| long term debt to capitalization | 0.42 |
| total debt to capitalization | 0.43 |
| interest coverage | 0.32 |
| cash flow to debt ratio | 0.25 |
cash flow ratios | |
|---|---|
| free cash flow per share | 3.49 |
| cash per share | 7.64 |
| operating cash flow per share | 4.12 |
| free cash flow operating cash flow ratio | 0.85 |
| cash flow coverage ratios | 0.25 |
| short term coverage ratios | 7.21 |
| capital expenditure coverage ratio | 6.53 |
Frequently Asked Questions
When was the last time ANI Pharmaceuticals, Inc. (NASDAQ:ANIP) reported earnings?
ANI Pharmaceuticals, Inc. (ANIP) published its most recent earnings results on 09-05-2025.
What is ANI Pharmaceuticals, Inc.'s current ROE?
An investor's main concern is the profitability ratios of a company so that they are able to understand how it performs financially. Investors are interested in finding out how effectively a business is using their cash to produce earnings, which is why return on equity (ROE) ratio is important. ANI Pharmaceuticals, Inc. (NASDAQ:ANIP)'s trailing twelve months ROE is -4.86%.
What are ROA telling us?
The Return on Assets (ROA) ratio measures how profitable a company is relative to its total assets. ANI Pharmaceuticals, Inc. (ANIP) currently has a ROA of -1.63%. Companies that manage their assets effectively will have greater returns, while those that do so poorly would suffer lower returns.
Where did ANIP's net profit margin stand at?
ANIP reported a profit margin of -3.12% in the last quarter. A company's profit margin, also known as its revenue ratio or gross profit ratio, reflects the amount of revenue that an organization earns compared to its net income. In general, a higher ratio implies greater profit, and vice versa.
What is ANIP's short-term liquidity position?
Apple's current ratio, which measures its ability to pay short-term obligations, was 2.66 in the most recent quarter. The quick ratio stood at 1.98, with a Debt/Eq ratio of 0.76.